SCHEMBL16692485

SCHEMBL16692485

Cc1ccc(-c2cn(-c3ccnc4[nH]ccc34)nc2C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 4/20 0.48
▸ IKBKB O14920 6/20 0.43
▸ CHUK O15111 5/20 0.43
▸ AURKB Q96GD4 2/20 0.43
▸ DAPK3 O43293 1/20 0.43
▸ JAK2 O60674 1/20 0.43
▸ PRKD3 O94806 1/20 0.43
▸ MAP4K4 O95819 1/20 0.43
▸ PAK4 O96013 1/20 0.43
▸ CSF1R P07333 1/20 0.43
▸ RET P07949 1/20 0.43
▸ IGF1R P08069 1/20 0.43
▸ FGFR1 P11362 1/20 0.43
▸ PRKACA P17612 1/20 0.43
▸ FLT1 P17948 1/20 0.43
▸ LTK P29376 1/20 0.43
▸ GRK5 P34947 1/20 0.43
▸ KDR P35968 1/20 0.43
▸ MAP2K2 P36507 1/20 0.43
▸ MAPK8 P45983 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29540441 0.90 AURKB (0.56) PRKCIIKBKBCHUKAURKBDAPK3
SCHEMBL98273 0.90 AURKB (0.56) PRKCIIKBKBCHUKAURKBDAPK3
SCHEMBL29540628 0.87 PRKCI (0.44) PRKCIIKBKBCHUKAURKBDAPK3
SCHEMBL99826 0.87 PRKCI (0.44) PRKCIIKBKBCHUKAURKBDAPK3
SCHEMBL99682 0.85 PRKCI (0.49) PRKCIIKBKBCHUKAURKBDAPK3
SCHEMBL29541194 0.85 PRKCI (0.49) PRKCIIKBKBCHUKAURKBDAPK3
SCHEMBL29540640 0.84 CIT (0.48) AURKBIGF1RROCK1AURKAINCENP
SCHEMBL98969 0.84 CIT (0.48) AURKBIGF1RROCK1AURKAINCENP
SCHEMBL29541139 0.84 PRKCI (0.45) PRKCIIKBKBCHUKAURKBDAPK3
SCHEMBL99293 0.84 PRKCI (0.45) PRKCIIKBKBCHUKAURKBDAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2348023-B1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors INCYTE CORP (US) 2015-05-06 — — EP disclosed
Send feedback